As of 3:59pm ET
| -0.05 / -1.67%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +205.08% increase from the last price of 2.95.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.